A global COVID-19 knowledge-sharing platform has secured three new licensing agreements to transfer vaccine technologies, including one with the first private manufacturer to join the initiative, the World Health Organization ...
Aug 29, 2023
0
1
A new fund to fast-track patient access to potentially valuable new medicines may incentivize the pharmaceutical industry to develop high priced drugs for rare diseases with weak evidence on clinical benefits.
Aug 25, 2023
0
1
Patients report that a ketogenic diet (KD) improves multiple sclerosis (MS) symptoms, according to a study published in the August issue of Clinical Nutrition.
Aug 22, 2023
0
3
For adults with moderate-to-severe atopic dermatitis (AD), dupilumab treatment yields significant improvement in sleep quality and other AD-related signs and symptoms, according to a study published online Aug. 10 in the ...
Aug 22, 2023
0
15
Tardive dyskinesia (TD) has a considerable impact on physical, psychological, social, and professional lives, according to a study published in the May/June issue of the Journal of Clinical Psychiatry.
Aug 22, 2023
0
2
Various medical circumstances, including heart attacks and extreme cases of COVID-19, necessitate the use of anticoagulants, medicines that prevent blood clots. But the most commonly used, heparin, can induce potentially ...
Aug 21, 2023
0
104
For patients with venous thromboembolism (VTE) continuing warfarin or direct oral anticoagulants (DOACs) beyond six months, the risk for recurrent VTE is lower with DOACs, according to a study published online Aug. 15 in ...
Aug 21, 2023
0
0
Most infants requiring intensive care for respiratory syncytial virus are born at term, and do not have underlying medical conditions, according to a study published online Aug. 15 in JAMA Network Open.
Aug 16, 2023
0
0
New cancer drugs are being launched rapidly before their long-term effectiveness for patients can be evaluated. Several years later, most of them still lack scientific evidence for increasing life expectancy or improving ...
Aug 15, 2023
0
7
Most adults initiating treatment with prescription opioids have relatively low and time-limited exposure to opioids during a five-year period, according to a study published online Aug. 10 in JAMA Network Open.
Aug 14, 2023
0
21
